Great to connect with members of BIG’s Patient Partnership Initiative during the 2025 BIG Scientific Meeting. @tanjaspanic.bsky.social , @evaschumacherwulf.bsky.social @christeeny513.bsky.social. Together, we’re working to ensure that patients’ voices help shape breast cancer research. 💗

Metastatic disease affects 20-30% of early breast cancer patients. This is the frontier where we need to focus.🎯

Mac4Me’s goal is to help transform metastatic breast cancer from a typically terminal condition into a chronic or potentially curable one.

#MetastaticBreastCancerAwarenessDay

Today, September 24th, is #WorldCancerResearchDay. It is a yearly momentum to raise
awareness and commitment for cancer research. This day also serves as a reminder that
progress depends on collaboration.

@oncoalert.bsky.social annual #ASCO25 5K on a beautiful morning in Chicago! Had some great running partners this am @quirogad.bsky.social @christeeny513.bsky.social

Perfect #ASCO25 morning - beautiful Chicago lakeside run with two amazing leaders in breast cancer care and advocacy 🏃‍♀️🙏🏽 @christeeny513.bsky.social @drgattimays.bsky.social @oncoalert.bsky.social @ascocancer.bsky.social

Thanks to these wonderful running buddies @drgattimays.bsky.social & @quirogad.bsky.social & @oncoalert.bsky.social for making it all happen!!

Fine-tune your strategies for using #HER2 targeting tx in HER2+ #MBC with and without #BrainMets: Get expert insight in this video from @PeerView & @graspcancer.bsky.social featuring Sara A. Hurvitz, MD, FACP, and colleagues. bit.ly/4fk0wD5

I'm sure glad I watched the triple negative MBC overview from
@hoperugo.bsky.social
which covered ongoing trials combining ADCs with immunotherapy as well as two novel bi-specific (two targets!) antibodies showing promise. I learned so much!

#OncoAlertColloquium #BreastCancer

.@drsgraff.bsky.social provides a clear overview of treatments for HER2+ MBC with a lot of discussion around those living with #brainmets. ADCs are now indicated for patients with active CNS disease #OncoAlertColloquium #BreastCancer

Excellent overview of the landscape for HR+ MBC by @erikahamilton9.bsky.social , I loved the schematic below of the different treatment algorithms for this subtype. #OncoAlertColloquium #BreastCancer

Excellent advocacy program with Living Beyond Breast Cancer (LBBC) specific to patients living with stage IV/metastatic disease! This program was the foundation for my advocacy work and you'll meet some pretty amazing peeps along the way as well ♥️

bit.ly/3tEqyP9

Are you living with metastatic breast cancer? Are you interested in liquid biopsy? Join us tomorrow for what is certain to be a lively discussion of two posters presented at SABCS24!

graspcancer.org/events/sabcs...

Really proud of my work wife (@itsnotpink.bsky.social) filling the shoes of the late Anne Loeser - the driving force & founder of @therightdose.bsky.social. She leaves a legacy that improves the lives of MBC patients who are on treatment indefinitely through drug dose optimization.

#SABCS2024 #bcsm

The FDA Oncology’s Project
Optimus aims to address dose optimization and was at least partly prompted by patients via PCDI #sabcs24

sabcs24

Love connecting with my favorite peeps including patients & oncologists at #SABCS2024 #OncoAlert #bcsm